India's most comprehensive portal on pharmaceutical News, Tenders, Patents, Notifications, Projects, Stocks, Drugs & Medicines

Athira Pharma inks license agreement with Sermonix Pharma to lasofoxifene phase 3 development programme

Join Pharma | Login

	Editorial


	THE 10-MINUTE DRUG DELIVERY CAMPAIGN
	Wednesday, December 17, 2025
	The Karnataka Pharma Retailers & Distributors Organization (KPRDO) has recently expressed concern over the partnership between Swiggy Instamart and PharmEasy for a rapid drug delivery model in Karnataka.
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	Athira Pharma inks license agreement with Sermonix Pharma to lasofoxifene phase 3 development programme
17:00 [IST]	BD and Penn Institute for Immunology and Immune Health Collaborate to advance immunotherapy through flow cytometry
16:00 [IST]	European Commission grants orphan drug designation to Memo Therapeutics’ potravitug to treat BKPyV infection in kidney transplant recipients
15:00 [IST]	Telo Genomics initiates multiple myeloma minimal residual disease trial in collaboration with the University of Athens
14:00 [IST]	Karl Landsteiner University study shows gut viruses persisting in water amoebae; urges evaluation of water safety rules
13:00 [IST]	Celltrion gets CHMP’s positive opinion for SteQeyma to treat plaque psoriasis, psoriatic arthritis & Crohn’s disease

more news >>

TOP NEWS


08:00 [IST]	Panel calls for nationally recognized quality standard for Ayush medicine
08:00 [IST]	Industry-regulator collaboration & power of AI to bring in compliance & quality discussed at IDMA 24th PAC
08:00 [IST]	Telangana DCA sensitizes pharmacies following statewide raids on 63 pharmacies for illegal sale of habit-forming drugs
08:00 [IST]	Karnataka FDA to engage 1,000 D Pharm students for apprenticeship with stipend
08:00 [IST]	AP Pharma JAC seeks invalidation of fraudulent votes in pharmacy council elections
08:00 [IST]	Indian pharma future calls for renewed thinking and global collaboration at IPC 2025

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Symeres earns first SBTi approval as part of long-term sustainability journey
14:30 [IST]	IPC 2025 begins on high note amid RGUHS, Karnataka FDA push for reliability of medicines
14:20 [IST]	Gleneagles Hospital Mumbai introduces the Institute of Onco-Science: A unified centre of excellence for cancer care
12:45 [IST]	Zydus Lifesciences inks exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India
12:30 [IST]	Telangana DCA raids 63 medical shops in state-wide crackdown
12:15 [IST]	iLive Connect launches ‘Doctor-Led Continuous Care platform, to aid healthcare beyond hospital

more news >>

INTERVIEW


Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana

Past Interviews...

	What's New?

tab. aripiprazole 10mg naproxen 500mg and sumatriptan 85mg oral tablet micronized calcium carbonate collagen peptides 40 mg + chondroitin sulphate 200 mg etc... levosalbutamol 50 mcg + ipratropium bromide 20 mcg

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers